Japan Has Agreed With AstraZeneca To Supply 120 Million Doses Of Coronavirus Vaccine
The Japanese government has reached a basic agreement with the British-Swedish pharmaceutical company AstraZeneca over the future supply of a coronavirus vaccine, according to the Ministry of Health, Labor, and Welfare of the country.
According to Reuters, the agreement provides that if the development of the vaccine is successful, AstraZeneca will provide Japan with 120 million doses. At the same time, a quarter of this volume can be delivered in the first quarter of next year.
AstraZeneca expects that clinical trials of the drug will be successfully completed by the fall. The company has already secured the necessary capacity to produce 2 billion doses of the coronavirus vaccine once it is created. Besides, AstraZeneca has already concluded several supply agreements with the United States, Great Britain, Italy, Germany, France, and the Netherlands.
On July 31, the Japanese authorities also signed a basic agreement with the American company Pfizer to supply the country with 60 million doses of a coronavirus vaccine if it is successfully developed.
In Japan, the development of a vaccine against coronavirus is the company, Anges Inc. In June, she received permission to conduct the first clinical trial of her drug in humans.
Since the beginning of the pandemic, about 19.1 million people have been infected with the coronavirus in the world, and about 715 thousand have died.